Aquestive Therapeutics (AQST) vs Alpha Teknova (TKNO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Alpha Teknova (TKNO) has outperformed Aquestive Therapeutics (AQST) over the past year, gaining 58.9% versus a loss of 23.2%. Over five years, AQST leads with a +23.0% price change compared with -63.5% for TKNO. Aquestive Therapeutics is the larger company by market cap ($597.4 million vs $453.1 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AQST | TKNO |
|---|---|---|
| Share price | $4.76 | $8.44 |
| Market cap | $597.44M | $453.13M |
| 1-day change | +3.03% | -3.10% |
| YTD return | -26.32% | +122.11% |
| 1-year return | -23.23% | +58.95% |
| 5-year return | +23.00% | -63.46% |
| EPS (TTM) | $-0.66 | $-0.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.55 | $9.48 |
| 52-week low | $2.93 | $1.91 |
| Distance from 52-week high | -36.95% | -10.97% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +96.01% | +6.64% |
| Average volume | 2.68M | 232.69K |
| Shares outstanding | 125.51M | 53.69M |
| Employees | 147 | 158 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TKNO has outperformed AQST by 82.2 percentage points over the past year.
About Aquestive Therapeutics
AQST stock →Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally.
Healthcare · Drug Manufacturers - Specialty & Generic · 147 employees
About Alpha Teknova
TKNO stock →Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.
Healthcare · Drug Manufacturers - Specialty & Generic · 158 employees
AQST vs TKNO FAQ
Which is bigger, Aquestive Therapeutics or Alpha Teknova?
Aquestive Therapeutics (AQST) is larger, with a market capitalization of $597.44M compared with $453.13M for Alpha Teknova (TKNO).
Which stock has performed better over the past year, AQST or TKNO?
TKNO returned +58.95% over the past 12 months, compared with -23.23% for AQST (price return, excluding dividends). Past performance does not predict future results.
Are Aquestive Therapeutics and Alpha Teknova in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.